Company Filing History:
Years Active: 2013-2014
Title: Discovering Pain Solutions: The Innovations of Danping Ding-Pfennigdorff
Introduction
Danping Ding-Pfennigdorff, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of pain research. With a remarkable portfolio of three patents, he focuses on identifying compounds involved in pain and developing methods for diagnosing algesia.
Latest Patents
Among his notable inventions are methods and uses relating to the identification of compounds involved in pain and methods of diagnosing algesia. His latest patents include:
1. A method of identifying a compound involved in pain, specifically utilizing Ctla2b nucleic acid or Ctla2b protein for this identification, along with methods for diagnosing algesia.
2. A similar method focusing on Epsti1 nucleic acid or Epsti1 protein, aimed at identifying compounds involved in pain and diagnosing algesia.
These innovations reflect a deep understanding of molecular biology and a commitment to addressing pain management challenges.
Career Highlights
Danping Ding-Pfennigdorff has established himself as a key player in the pharmaceutical industry through his work at Sanofi. His research has pivotal implications for the development of new therapeutic approaches for pain relief.
Collaborations
Throughout his career, Ding-Pfennigdorff has collaborated with esteemed colleagues, including Mathias Gebauer and Martin Michaelis. This synergy among innovative minds has fostered advancements in understanding pain mechanisms and identifying potential treatment avenues.
Conclusion
Danping Ding-Pfennigdorff continues to make strides in pain research, with his innovative patents paving the way for improved diagnostic methods and therapeutic solutions. His work exemplifies the critical role inventors play in advancing medical science and enhancing patient care.